0 items USD 0.00Search
Your search for "qyresearch global acute lymphoblastic leukemia therapeutics industry 2015 market research report" gave back 688394 results.
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
The global Medical Asparaginase market size was valued at US$ 395.2 million in 2023. With growing demand in downstream market, the Medical...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Medical FLT3 inhibitor is a type of medication that targets and inhibits the activity of the FLT3 receptor, a protein found on the surface of certain...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a malignant tumor disease in which B or T cells of lymphocytes proliferate abnormally in the bone marrow...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Leukemia Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Leukemia Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Leukemia Cancer is forecast...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Market Analysis and Insights: Global Leukemia Cancer Market The global Leukemia Cancer market is projected to grow from US$ million in 2023 to US$...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Acute Myeloid Leukemia (AML) Therapeutics market was valued at US$ 543.8 million in 2023 and is anticipated to reach US$ 1145.5 million by...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Nelarabine market is projected to reach US$ 146.3 million...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Atriance market is projected to reach US$ 62 million in 2029...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Arranon market is projected to reach US$ 85 million in 2029,...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
